Soleno Therapeutics
SLNO
SLNO
231 hedge funds and large institutions have $4.75B invested in Soleno Therapeutics in 2025 Q2 according to their latest regulatory filings, with 50 funds opening new positions, 106 increasing their positions, 57 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
6.38% less ownership
Funds ownership: 118.99% → 112.61% (-6.4%)
10% less call options, than puts
Call options by funds: $163M | Put options by funds: $181M
16% less funds holding in top 10
Funds holding in top 10: 19 → 16 (-3)
Holders
231
Holding in Top 10
16
Calls
$163M
Puts
$181M
Top Buyers
| 1 | +$92.5M | |
| 2 | +$88.9M | |
| 3 | +$78M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$52.1M |
| 5 |
NNPTE
Nationale-Nederlanden Powszechne Towarzystwo Emerytalne
Warszawa,
Poland
|
+$42.1M |
Top Sellers
| 1 | -$90.2M | |
| 2 | -$68.4M | |
| 3 | -$65.4M | |
| 4 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$63.3M |
| 5 |
CC
Commodore Capital
New York
|
-$45.2M |
